Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.265.25 CHF
Change Today -0.75 / -0.28%
Volume 1.2K
STMN On Other Exchanges
Symbol
Exchange
Munich
SIX Swiss Ex
OTC US
As of 3:22 AM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

straumann holding ag-reg (STMN) Snapshot

Open
SFr.266.75
Previous Close
SFr.266.00
Day High
SFr.267.50
Day Low
SFr.265.00
52 Week High
01/15/15 - SFr.279.50
52 Week Low
05/7/14 - SFr.189.70
Market Cap
4.2B
Average Volume 10 Days
31.1K
EPS TTM
SFr.10.15
Shares Outstanding
15.7M
EX-Date
04/14/15
P/E TM
26.1x
Dividend
SFr.3.75
Dividend Yield
1.40%
Current Stock Chart for STRAUMANN HOLDING AG-REG (STMN)

Related News

No related news articles were found.

straumann holding ag-reg (STMN) Related Businessweek News

No Related Businessweek News Found

straumann holding ag-reg (STMN) Details

Straumann Holding AG provides tooth replacement solutions. It researches, develops, and manufactures dental implants, instruments, prosthetics, and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. The company offers replacement solutions, including soft tissue level and bone level implants; SLActive bone formation surface; and Roxolid implants used to replace individual teeth, carry multi-unit bridges, and attach fixed or removable full dentures. It also provides prosthetic components and tools, as well as precision instruments, guided surgery tools, and handling components. In addition, the company offers digital solutions, including guided surgery, intra-oral scanning, and CADCAM; and oral tissue regeneration solutions comprising Emdogain, bone substitutes, membranes, soft tissue grafts, and fleeces. Further, it provides training and education services to its customers. The company offers its products to dental professionals and dental laboratories in approximately 70 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

2,390 Employees
Last Reported Date: 02/27/15
Founded in 1954

straumann holding ag-reg (STMN) Top Compensated Officers

Chief Executive Officer and Member of Executi...
Total Annual Compensation: SFr.2.0M
Compensation as of Fiscal Year 2014.

straumann holding ag-reg (STMN) Key Developments

Straumann Reports Revenue Results for the First Quarter of 2015; Reaffirms Earnings Guidance for 2015

Straumann reported revenue results for the first quarter of 2015. The company's revenues in the first quarter climbed 7% to CHF 193 million (EUR 183.6 million/USD 205.5 million), helped by growth at all units and strong performance in the Asia/Pacific region. The company said organic growth in the first three months of the year was 8%. The company reiterated it aims for its earnings before interest and tax (EBIT) margin to grow to at least 20% in 2015, helped by measures aimed at mitigating the impact of the strong Swiss franc.

Straumann Holding AG to Report Q1, 2015 Sales/Trading Statement Results on Apr 30, 2015

Straumann Holding AG announced that they will report Q1, 2015 sales/trading statement results at 6:30 AM, Central European Standard Time on Apr 30, 2015

Straumann Appoints Petra Rumpf as Head of Instradent & Strategic Alliances and Member of Executive Management Board, Effective 30 March 2015

Straumann announced the appointment of Petra Rumpf as Head of Instradent & Strategic Alliances and Member of the Executive Management Board, starting 30 March 2015. Prior to joining Straumann, Petra Rumpf spent almost seven years at Nobel Biocare, where she was a Member of the Executive Committee with responsibility for corporate development, mergers & acquisitions, the expansion of the company's value brand, AlphaBio Tec, and a portfolio of global and regional businesses in the premium segment. She takes over her new responsibilities from CEO Marco Gadola, who has supervised them directly, ad-interim.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STMN:SW SFr.265.25 CHF -0.75

STMN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
View Industry Companies
 

Industry Analysis

STMN

Industry Average

Valuation STMN Industry Range
Price/Earnings 28.3x
Price/Sales 6.2x
Price/Book 6.0x
Price/Cash Flow 28.2x
TEV/Sales 5.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STRAUMANN HOLDING AG-REG, please visit www.straumann.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.